Aczone
In brief
- In our pharmacy you can buy aczone without a prescription, with delivery across Australia (discreet packaging); note that national regulators generally classify Aczone (dapsone gel) as prescription‑only, so availability may vary by outlet.
- Aczone (dapsone) is used to treat inflammatory acne (acne vulgaris). It has antibacterial activity against Cutibacterium acnes and anti‑inflammatory properties—its exact topical mechanism is not fully understood but likely involves inhibition of neutrophil‑mediated inflammation.
- Usual dose: 5% gel — apply a thin layer once or twice daily (licensed for ≥12 years); 7.5% gel — apply a thin layer once daily (licensed for ≥9 years). Apply a pea‑sized amount to the affected areas; reassess if no improvement after 12 weeks.
- Form of administration: topical gel (tube or multi‑use dispenser) applied to clean, dry skin; not for oral, ophthalmic or intravaginal use.
- Onset time: some initial improvement may be seen within a few weeks; noticeable effects commonly appear over several weeks.
- Duration of action: treatment courses are typically up to 12 weeks with full effect often reached by about 3 months; continue as directed by your clinician until reassessment.
- Alcohol warning: there is no specific alcohol restriction for topical Aczone, but avoid excessive alcohol if you have anaemia or G6PD deficiency or if you are using oral dapsone; discuss with a healthcare professional if concerned.
- The most common side effects are dryness and redness of the skin; other local effects include burning, stinging, itching, oiliness or peeling. Rare but serious reactions include methemoglobinaemia and haemolytic anaemia (higher risk with G6PD deficiency).
- Would you like to try “aczone” without a prescription?
Basic Aczone Information
- INN (International Nonproprietary Name): Dapsone (also known as 4,4’-diaminodiphenylsulfone; CAS: 80‑08‑0).
- Brand Names Available In Australia: Aczone® is the primary worldwide brand (distributed by Allergan, Inc.) and the product is marketed in the US, Canada and New Zealand; generic dapsone gel exists internationally — confirm local Australian availability via the TGA ARTG (not specified in the raw data).
- ATC Code: D10AX05 (Other anti‑acne preparations for topical use).
- Forms & Dosages: Gel formulations sold as 5% and 7.5% strengths in tubes/dispensers.
Standard dosing: 5% gel for ≥12 years (once or twice daily); 7.5% gel for ≥9 years (once daily); typical course up to 12 weeks. - Manufacturers In Australia: Allergan, Inc. is the global supplier for Aczone®; multiple generic manufacturers exist internationally (Teva, Alkem, Amneal, etc.).
- Registration Status In Australia: Registration on the TGA ARTG is not specified in the supplied data; confirm current registration and sponsor on the TGA website before stocking or recommending.
- OTC / Rx Classification: Prescription only (Rx‑only) in jurisdictions referenced in the raw data; check the TGA ARTG and PBS for current Australian classification and subsidy status.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
What Are The Main Safety Concerns?
Dapsone topical (dapsone gel, e.g. Aczone®) can cause haemolysis and methemoglobinaemia in rare cases.
These blood reactions are most relevant for patients with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency, people with severe anaemia, or anyone with a prior history of methemoglobinaemia.
Topical absorption is generally minimal, but systemic effects have been documented and warrant caution in high‑risk patients.
Pregnancy And Breastfeeding
Topical absorption is low but data on pregnancy and lactation are limited.
Use during pregnancy or breastfeeding only if the prescriber judges that the likely benefit outweighs the potential risk.
Counsel pregnant or breastfeeding patients about the limited safety data and document the shared decision making.
Elderly And Chronic Illness
No formal dose adjustments are specified for elderly patients in the product information.
Monitor older patients for local irritation and any unexpected systemic symptoms and review concomitant medicines for interactions.
Consider closer follow‑up if significant comorbidities or polypharmacy are present.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Topical dapsone rarely causes systemic effects and most people will have no impairment from using it.
If a patient develops dizziness, breathlessness or severe fatigue while using dapsone gel, they should not drive or operate heavy machinery until the symptoms resolve.
Record any adverse effects in the patient notes and advise workplace adjustments if needed, consistent with workplace safety obligations in Australia.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Generally yes.
If you have no systemic symptoms such as dizziness or breathlessness, driving is usually safe after applying topical dapsone.
If you develop systemic symptoms, do not drive and seek medical help.
- If symptoms occur: Stop product → Seek urgent advice → Do not drive.
INN, Brands And Legal Classification In Australia
INN And Brand Names Available (Australian Context)
INN: dapsone (4,4’‑diaminodiphenylsulfone; CAS: 80‑08‑0).
The primary commercial brand internationally is Aczone®, distributed by Allergan, Inc.
Aczone and generic dapsone gel are available internationally as 5% and 7.5% gels in tubes and multi‑use dispensers.
Confirm local Australian marketing and supplier details via the TGA ARTG before assuming availability.
Legal Classification (TGA Approval, PBS Listing)
Topical dapsone is classified as prescription‑only (Rx‑only) in the jurisdictions provided in the raw data.
For Australia, check the TGA Australian Register of Therapeutic Goods (ARTG) for registration and the PBS for subsidy information.
Many topical acne agents are prescription medicines and may not be PBS‑subsidised, so price sensitivity is common among patients.
| INN/Brand | Strength | Usual Packaging | Rx Status |
|---|---|---|---|
| Aczone® / Dapsone | 5% | Tubes / Multi‑use Dispensers | Prescription only (Rx‑only) |
| Aczone® / Dapsone | 7.5% (75 mg/g) | Tubes / Multi‑use Dispensers | Prescription only (Rx‑only) |
| Dapsone (generic) | 5%, 7.5% | Tubes / Multi‑use Dispensers | Prescription only (Rx‑only) |
Dosing Guide (Practical Regimen And Adjustments)
Standard Regimens (Reference Dosing From Product Information)
For patients aged 12 years and older, the 5% gel is applied as a thin layer once or twice daily.
For patients aged nine years and older, the 7.5% gel is applied as a thin layer once daily.
Apply a pea‑sized amount to the entire affected area on clean, dry skin and rub in gently and completely.
Typical courses run up to 12 weeks, with reassessment if there is no improvement by 12 weeks.
Initial improvement is usually seen within weeks, and full benefit may take approximately three months.
Adjustments For Comorbidities And Special Groups
Children: follow the stated age limits (5% for ≥12 years; 7.5% for ≥9 years).
Elderly: no routine dose change is specified, but monitor for adverse effects and interactions.
Liver / kidney impairment: systemic absorption is limited but data are insufficient for formal dose recommendations; seek specialist advice for significant organ dysfunction.
Overdose / Missed Dose: apply as soon as remembered; if it is almost time for the next application, skip the missed dose and do not double up.
Topical overdose rarely causes serious harm, but accidental ingestion can lead to haematological reactions and requires urgent poison centre guidance.
Q&A — “What If I Miss A Dose?”
Apply as soon as you remember.
If it is nearly time for the next dose, skip the missed dose rather than doubling up.
- Routine checklist: Morning/evening routine → Amount (pea‑sized) → Avoid doubling.
Interaction Chart (Food, Drinks, Drugs)
Food And Drinks (Alcohol, Caffeine, Australian Diet Context)
Topical dapsone has minimal systemic absorption and no established direct food or drink interactions.
If systemic absorption is increased — for example through use on damaged or extensive skin — be cautious with agents that raise methemoglobin or cause haemolysis.
Advise moderation of alcohol if systemic symptoms occur, as alcohol can worsen general fatigue and breathlessness.
Common Drug Conflicts (Topicals, Systemic Meds)
Benzoyl peroxide applied with dapsone topical can cause a temporary yellow/orange discolouration of the skin or staining of fabrics.
Systemic oxidising agents that can increase methemoglobin or haemolysis risk may theoretically interact if systemic exposure to dapsone occurs.
Examples to flag for pharmacist review include certain nitrates, local anaesthetics such as prilocaine, and high‑dose sulfonamides.
| Agent / Food | Risk | Action |
|---|---|---|
| Benzoyl Peroxide | Local staining / discolouration | Avoid simultaneous application; counsel on possible yellow/orange staining of skin and fabrics; consider staggered use. |
| Prilocaine / Other Oxidising Local Anaesthetics | Theoretical increased methemoglobinaemia risk (if systemic exposure occurs) | Flag for pharmacist/clinician review in high‑risk patients. |
| Nitrates / High‑Dose Sulfonamides | Theoretical haemolysis / methemoglobinaemia risk | Assess medication history and monitor if significant topical exposure is suspected. |
- Immediate counselling points: screen for G6PD deficiency, warn about staining with benzoyl peroxide, advise to stop and seek urgent care for breathlessness or severe fatigue.
User Reports & Trends (Australian Patient Feedback)
What Patients Commonly Say.
Consumers report that initial improvement from dapsone gel takes several weeks and full response can take up to three months.
Local side effects reported most often are dryness, redness, burning or stinging at the application site.
Systemic effects such as methemoglobinaemia or haemolytic anaemia are reported but are very uncommon with topical use.
Concurrent use with benzoyl peroxide is frequently associated with temporary staining and many users note this in reviews.
Some patients prefer the convenience of once‑daily 7.5% gel, while others tolerate the 5% formulation used once or twice daily better.
- Top Reported Positives: Reduction in inflamed pimples, useful when antibiotics are not suitable, convenient 7.5% once‑daily option.
- Top Reported Negatives: Local irritation, possible staining with benzoyl peroxide, variable time to effect.
| Adverse Event | Typical Incidence (Reported) |
|---|---|
| Local Dryness / Redness | Common |
| Burning / Stinging | Common |
| Methemoglobinaemia | Rare |
| Haemolytic Anaemia | Very Rare |
Note: Online reviews are anecdotal and should be balanced with clinical evidence when advising patients.
Access & Purchase Options In Australia
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Topical prescription acne treatments are dispensed through major pharmacy chains and independent pharmacies across Australia.
Patients commonly compare prices across retailers such as Chemist Warehouse, Priceline and local pharmacy groups and should ask about dispensing fees and generic options.
Confirm whether a specific product is stocked locally by searching pharmacy inventories online or calling ahead.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth e‑prescriptions from accredited services are widely accepted by Australian pharmacies and are a practical option for remote patients.
Online pharmacies may deliver to rural areas; check for temperature exposure risks during transit and inspect the product on arrival.
In our online pharmacy, aczone is available without a prescription, with discreet delivery to Australia in 9‑21 days.
- Before ordering checklist: Prescription (if required), photo ID, preferred pharmacy, delivery instructions, storage notes (room temperature), check PBS or private health rebates.
Mechanism Of Action & Pharmacology (Plain And Clinical Terms)
Simplified Explanation For Patients
Dapsone topical reduces inflammatory acne lesions mainly by anti‑inflammatory action and has modest antibacterial effects.
It calms inflamed pimples and pustules rather than primarily unclogging pores.
Clinical Pharmacology Terms
ATC Classification: D10AX05 — other anti‑acne topical preparations.
Pharmacodynamics: topical dapsone modulates neutrophil activity and reduces inflammatory mediators at the local site.
Pharmacokinetics: systemic absorption through intact skin is minimal, which is why systemic adverse effects are rare but possible.
- Methemoglobinaemia: Reduced oxygen‑carrying capacity of blood due to oxidised haemoglobin.
- Haemolysis: Breakdown of red blood cells, which can cause anaemia.
Suggestion for blog use: include a small diagram showing ‘Topical Application → Local Anti‑Inflammatory Action → Lesion Reduction’ for patient clarity.
Indications & Off‑Label Uses
Approved Indications (Practical Wording)
Where marketed, topical dapsone is indicated for inflammatory acne vulgaris.
The product information refers to use for persistent inflammatory acne and is commonly used in adult female acne in practice.
Always confirm the specific TGA wording in the ARTG for Australia prior to prescribing or promoting the product.
Off‑Label Uses In Australian Practice
Clinicians may consider topical dapsone for acne resistant to conventional first‑line agents or when antibiotics are unsuitable.
Off‑label use should be documented, explained to the patient and considered after specialist or dermatology input where appropriate.
- Off‑label suitability checklist: Age limits, screen for G6PD status, prior treatment history, informed consent, monitoring plan.
Key Clinical Findings (International & Australian Studies 2022–2026)
Efficacy from randomised controlled trials shows significant reductions in inflammatory lesion counts versus placebo over weeks.
Onset of effect is in weeks with maximum benefit around 12 weeks in many trials.
Comparison of strengths: vehicle and concentration (5% vs 7.5%) affect dosing frequency and patient convenience; 7.5% is once daily while 5% may be once or twice daily.
Safety profile in trials is dominated by local skin adverse events such as dryness and redness; serious systemic events are rare but documented.
- Suggested evidence presentation: bullet list of RCT outcomes and a small table comparing 5% vs 7.5% for efficacy and dosing frequency when publishing.
| Strength | Dosing Frequency | Typical Clinical Use |
|---|---|---|
| 5% | Once or Twice Daily | Adolescents ≥12 and adults; flexible dosing |
| 7.5% | Once Daily | Patients ≥9; once‑daily convenience |
Include citations to RCTs and regulatory sources such as FDA product information and local TGA ARTG entries when publishing.
Alternatives Matrix (Selection, PBS Alternatives)
Common topical alternatives include benzoyl peroxide, adapalene (Differin), adapalene/benzoyl peroxide combinations (Epiduo) and topical clindamycin.
| Product / INN | Mechanism | Typical Use Case | PBS Status | Pros / Cons |
|---|---|---|---|---|
| Benzoyl Peroxide | Oxidising antibacterial / keratolytic | Comedonal and inflammatory acne | Variable (check PBS) | Effective; may bleach fabrics; non‑antibiotic |
| Adapalene (Differin) | Topical retinoid | Comedonal acne, maintenance | Variable (check PBS) | Good for comedones; photosensitivity; best used at night |
| Clindamycin (Topical) | Topical antibiotic | Inflammatory acne (short term) | Variable (check PBS) | Resistance risk; often combined with benzoyl peroxide |
- Quick pros & cons checklist: Benzoyl peroxide — non‑antibiotic and effective but may bleach; Adapalene — effective for comedonal acne but can irritate; Clindamycin — antibiotic stewardship concerns.
Common Questions From Australian Pharmacy Consultations
What Are The Common Side Effects?
Local dryness, redness, burning or stinging are common.
Rare systemic haematological events such as methemoglobinaemia or haemolytic anaemia have been reported and require urgent care.
Can I Combine With Other Topicals?
Caution combining with benzoyl peroxide because of staining, and avoid layering multiple strong irritants — stagger applications if needed.
Pregnancy / Breastfeeding?
Use only if necessary; topical exposure is low but data are limited — discuss with the prescriber.
How Long Until Results?
Expect initial improvement within weeks and reassess therapy at around 12 weeks if there is no benefit.
- Pharmacist cue cards: Check age limits, screen for G6PD risk factors, advise pea‑sized application, laundering tips to avoid staining, and an action plan for adverse effects.
Price & Access Comparison (Pharmacy / Source Table)
Current prices vary and can change frequently.
Rather than invent prices, use the template below and check live prices at Chemist Warehouse, Priceline, TerryWhite Chemmart and local compounding pharmacies.
| Pharmacy / Source | Typical Price Range | PBS Subsidy Status | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Check current price | Check PBS | Yes (per product info) |
| Priceline | Check current price | Check PBS | Yes (per product info) |
| TerryWhite Chemmart | Check current price | Check PBS | Yes (per product info) |
| Compounding Pharmacy | Check current price | Check PBS | Yes (may compound alternative strengths) |
- Access checklist: GP or telehealth script, call pharmacy to confirm stock, ask about generics or compounding, consider rural delivery times and storage on arrival.
Registration & Regulation (TGA, PBS, Record Keeping)
TGA Approval & ARTG Checks
Before recommending or stocking, verify the product’s registration on the TGA ARTG and confirm the Australian sponsor details.
Do not assume availability in Australia based on overseas marketing (for example Aczone® is marketed in the US and New Zealand per the raw data).
Pharmacies should document supply, counselling and any adverse events in accordance with TGA guidance.
PBS Subsidy Details And Prescribing Rules
PBS listing and subsidy vary by product and indication; many topical acne medicines are not PBS‑listed, so check the PBS Schedule before prescribing if affordability is a concern.
Pharmacists should be prepared to discuss alternatives when patients cannot afford unsubsidised options.
- Regulatory verification checklist: Check ARTG entry → Confirm sponsor → Check PBS status → Document counselling and adverse events.
Storage & Handling (Home And Pharmacy)
Household Storage In Australian Climate (Heat / Humidity)
Store dapsone gel at room temperature up to 25°C (77°F) and avoid freezing.
Protect the product from excessive heat and light and keep it tightly closed in the original packaging.
Advise patients in hot Australian summers to keep the tube in a cool, shaded place and never to leave it in a hot car.
If delivery occurs during hot weather, inspect the product for changes in appearance and consult the dispensing pharmacist if unsure.
Cold‑Chain Handling For Pharmacies
Dapsone gels do not require refrigeration but must be stored per the manufacturer’s recommendations and protected from heat.
Maintain temperature logs and batch records as part of pharmacy quality systems.
- Storage checklist: Storage temperature ≤25°C, check expiry and batch number, document delivery condition, store in original packaging.
Guidelines For Proper Use & Pharmacist Counselling Points
Australian Pharmacist Counselling Style — Step‑By‑Step
Confirm the patient’s age and ask about any allergies to sulfone or sulfonamide medicines.
Screen for G6PD deficiency or a personal/family history of haemolytic anaemia or methemoglobinaemia.
Explain how to apply: a pea‑sized amount to clean, dry skin, avoiding eyes and mouth, rubbing in gently.
Review dosing frequency: 5% once or twice daily for patients ≥12; 7.5% once daily for patients ≥9.
Set expectations: some improvement within weeks, reassess at 12 weeks if ineffective.
Warn about common AEs: local irritation and staining if combined with benzoyl peroxide.
Provide an action plan: stop immediately and seek urgent care for breathlessness, rapid heartbeat, severe pallor or jaundice, and report events to the pharmacy and prescriber.
Patient Resources & National Guidance
Offer a printed or emailed aftercare sheet that covers application steps, laundering tips to avoid staining, when to seek help and telehealth follow‑up options.
Refer complex or refractory cases to a dermatologist.
- Dispense checklist for dapsone gel: Verify prescription, screen for contraindications, provide counselling points, supply patient information leaflet, arrange 12‑week follow‑up, document consent for off‑label use where relevant.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9‑14 days |
| Melbourne | Victoria | 9‑14 days |
| Brisbane | Queensland | 9‑14 days |
| Perth | Western Australia | 9‑14 days |
| Adelaide | South Australia | 9‑14 days |
| Canberra | Australian Capital Territory | 9‑14 days |
| Hobart | Tasmania | 9‑14 days |
| Darwin | Northern Territory | 9‑14 days |
| Gold Coast | Queensland | 9‑14 days |
| Newcastle | New South Wales | 14‑21 days |
| Wollongong | New South Wales | 14‑21 days |
| Geelong | Victoria | 14‑21 days |
Final Safety Reminder.
Dapsone topical is an effective option for inflammatory acne but requires appropriate screening and counselling.
Always check TGA ARTG for Australian registration status and PBS for subsidy details before recommending or stocking the product.
Stop treatment and seek urgent medical attention for any signs of breathlessness, pronounced pallor, jaundice or severe fatigue.